# Micell Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/micell-technologies

- Industry: Biopolymers
- Headquarters: Durham, US
- Website: www.micell.com
- Total disclosed funding: $22M
- Latest round: Series B (Oct 1, 2009)
- Investors on record: 4

## About

Founded in 1995 and based in North Carolina, US, Micell Technologies, Inc. operates as a developer of biopolymers, drugs and other biomedical solutions to treat cardiovascular diseases.

## Funding rounds

- Series B, Oct 1, 2009, $15M — GE Capital, Equity, Invemed Associates, St. Jude Medical
- Series A, Jul 5, 2007, $1.5M — Invemed Associates
- Series A, Jun 13, 2007, $5M — Invemed Associates, GE Capital

## Investors

- Invemed Associates (https://capitalatlas.ai/funds/invemed-associates) — Series A, Series B
- GE Capital — Series A
- GE Capital, Equity (https://capitalatlas.ai/funds/ge-capital-equity) — Series B
- St. Jude Medical — Series B